Drug Trial Radar · NCT07566195
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
59
Planned (sponsor's estimate)
Start
May 5, 2026
Primary completion
Dec 29, 2028
Study completion Dec 29, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Clinact, Multihealth Group; Contract Research Organization
- First posted
- May 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ROMEO is a Phase III, multicentre, open-label, chronic-dosing extension study evaluating the long-term safety of two dose regimens of tozorakimab in participants with COPD and a history of exacerbations. Eligible participants must have completed one of the predecessor studies.
Conditions
- Chronic Obstructive Pulmonary Disease
- COPD
Interventions
Tozorakimab Dose Regimen 1Drug
Participants previously randomised in the MIRANDA predecessor study will receive Tozorakimab in ROMEO according to this dose regimen
Tozorakimab Dose Regimen 2Drug
Participants previously randomised in the TITANIA or PROSPERO predecessor studies will receive Tozorakimab in ROMEO according to this dose regimen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: 2-3 years
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Aix-en-Provence, France · Active not recruiting
Research Site
Brest, France · Active not recruiting
Research Site
Colmar, France · Withdrawn
Research Site
Gleizé, France · Active not recruiting
Research Site
Grenoble, France · Recruiting
Research Site
Lyon, France · Recruiting
Research Site
Marseille, France · Recruiting
Research Site
Montpellier, France · Recruiting
Research Site
Pessac, France · Recruiting
Research Site
Pringy, France · Active not recruiting
Research Site
Quimper, France · Active not recruiting
Research Site
Saint-Herblain, France · Active not recruiting
Research Site
Toulouse, France · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.